vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics
vTv Therapeutics Inc. - (VTVT)
Today's Latest Price: $1.49 USD
0.01 (-0.67%)
Updated Dec 6 12:00am
Add VTVT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VTVT Stock Summary
- vTv Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 6.26% of US listed stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -0.16 for vTv Therapeutics Inc; that's greater than it is for only 5.82% of US stocks.
- With a year-over-year growth in debt of -51.14%, vTv Therapeutics Inc's debt growth rate surpasses merely 6.01% of about US stocks.
- Stocks that are quantitatively similar to VTVT, based on their financial statements, market capitalization, and price volatility, are PFNX, HTBX, AVEO, OMER, and CRIS.
- VTVT's SEC filings can be seen here. And to visit vTv Therapeutics Inc's official web site, go to www.vtvtherapeutics.com.
VTVT Daily Price Range
VTVT 52-Week Price Range
VTVT Stock Price Chart More Charts
VTVT Price/Volume Stats
Current price | $1.49 |
Prev. close | $1.50 |
Day low | $1.49 |
Day high | $1.53 |
50-day MA | $1.48 |
200-day MA | $1.54 |
52-week high | $3.50 |
52-week low | $1.00 |
Volume | 51,000 |
Avg. volume | 676,906 |
Dividend yield | N/A |
Market Cap | 80.66M |
vTv Therapeutics Inc. - (VTVT) Company Bio
vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.
Loading social stream, please wait...